Stocktoria
Decoy Therapeutics Inc. DCOY
Decoy Therapeutics Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $1.8M | $5.2M | $3.5M | $2.0M | $1.3M | $1.0M |
| R&D expense | $368,170 | $770,027 | $7.2M | $15.8M | $8.5M | $6.9M | $4.0M | $1.3M | $17.0M | $20.4M |
| Operating income | -$12.6M | -$5.7M | -$12.9M | -$31.8M | -$12.8M | -$7.8M | -$8.3M | -$1.7M | -$34.7M | -$39.9M |
| Income tax | $0 | — | — | — | — | — | $0 | — | — | — |
| Net income | -$12.5M | -$5.6M | -$12.5M | -$31.6M | -$12.8M | -$7.4M | -$6.9M | -$1.7M | -$34.4M | -$39.5M |
| EPS (diluted) | $-129.10 | $-69.54 | $-30.74 | $-14.88 | $-7.72 | $-0.50 | — | — | — | — |
| Operating cash flow | -$4.8M | -$4.5M | -$12.8M | -$17.6M | -$10.2M | -$10.3M | -$11.6M | $4.2M | -$27.7M | -$32.1M |
| Free cash flow | — | — | — | — | -$10.2M | -$10.3M | -$11.6M | $4.2M | -$27.8M | -$32.6M |
| Cash & equivalents | $10.7M | $2.4M | $5.9M | $12.1M | $29.2M | $11.1M | $3.7M | $3.2M | $19.2M | — |
| Inventory | — | — | — | — | — | — | — | $186,920 | $431,891 | $454,132 |
| Total assets | $11.1M | $3.0M | $6.6M | $14.7M | $40.8M | $24.9M | $13.9M | $6.6M | $35.0M | $63.2M |
| Total liabilities | $5.2M | $1.5M | $1.3M | $4.3M | $2.1M | $2.8M | $3.3M | $7.9M | $5.9M | $3.9M |
| Shareholders' equity | $5.9M | $1.5M | $5.3M | $10.4M | $38.7M | $22.2M | $10.6M | -$1.3M | -$2.9M | $59.3M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | -100.0% | -64.8% | +51.0% | +77.6% | +53.1% | +26.1% | — |
| Free cash flow growth | — | — | — | — | — | — | -377.2% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.